Eris Biotech (YC Winter 2024)

TL;DR: Eris Biotech is a Y Combinator Winter 2024 startup Our drugs engage the immune system to fight tumors, currently active with a team of 2.

Our drugs engage the immune system to fight tumors

YC ID
29470
YC Batch
Winter 2024
Status
Active
Team size
2
Industry
Healthcare, Therapeutics
Tags
Biotech, Therapeutics, Drug discovery
YC profile
https://www.ycombinator.com/companies/eris-biotech

Last verified:

We are developing cancer therapeutics using small molecules that inhibit immune suppression. Our drugs engage the immune system to aggressively fight tumors. Our therapeutic portfolio addresses a range of solid tumors, starting with mesothelioma.

Built by LemStudio

Building or buying SaaS? Try our founder tools →

Frequently asked questions

Is Eris Biotech a YC (Y Combinator) company?

Yes. Eris Biotech was funded by Y Combinator in the Winter 2024 batch. Our drugs engage the immune system to fight tumors

What does Eris Biotech do?

We are developing cancer therapeutics using small molecules that inhibit immune suppression. Our drugs engage the immune system to aggressively fight tumors. Our therapeutic portfolio addresses a range of solid tumors, starting with mesothelioma.

What YC batch was Eris Biotech in?

Eris Biotech was part of Y Combinator's Winter 2024 batch.

How big is Eris Biotech?

Eris Biotech has a team of 2 people according to Y Combinator's directory.

Is Eris Biotech still active?

Eris Biotech is currently listed as Active with a team of 2 in Y Combinator's directory.

More YC Winter 2024 companies

More Healthcare YC startups

Explore related YC hubs

Loading interactive view…